Подкатегории
Semisynthetic antitumor agent of plant origin, obtained by chemical synthesis from natural raw materials - European yew needles (Taxus baccata). White or almost white powder, highly lipophilic and practically insoluble in water. The molecular weight of 861.9.
Semisynthetic antitumor agent of plant origin, obtained by chemical synthesis from natural raw materials - European yew needles (Taxus baccata). White or almost white powder, highly lipophilic and practically insoluble in water. The molecular weight of 861.9.
The medicine is used to treat adult patients with a type of skin cancer called melanoma, which has spread to the skin or lymph nodes and cannot be removed surgically.
Kyprolis (Carfilzomib) is a targeted antitumor drug used in the diagnosis of recurrent multiple myeloma, when the patient has already received 1-2 treatments and they have been ineffective.
chronic myeloid leukemia (CML) in adults in the presence of the T1315I mutation; chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in the presence of the Philadelphia chromosome, in adults who are not suitable for any of the other protein tyrosine kinase inhibitors.
chronic myeloid leukemia (CML) in adults in the presence of the T1315I mutation; chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in the presence of the Philadelphia chromosome, in adults who are not suitable for any of the other protein tyrosine kinase inhibitors.
Xtandi® is a drug for treating advanced prostate cancer. Kstandi is used for the treatment of metastatic prostate cancer, which is not amenable to surgical or drug therapy aimed at lowering testosterone levels.
Patients with mild to moderate impaired renal function do not require dose adjustment.
Contraindicated in severe renal failure (creatinine clearance less than 20 ml / min).
prescription
Manufacturer AstraZeneca